No New Trial In Pennsylvania Risperdal Breast Growth Trial; Delay Damages Added

(January 29, 2016, 9:27 AM EST) -- PHILADELPHIA — A Pennsylvania state court judge on Jan. 5 denied a Risperdal plaintiff’s motion for a new trial but granted his motion for delay damages of $35,106, bringing to $535,106 the plaintiff’s recovery against Janssen Pharmaceuticals Inc. (Timothy Stange v. Janssen Pharmaceuticals, Inc., et al., No. 130401984, Pa. Comm. Pls., Philadelphia Co.)....

Related Sections